Haematology Flashcards
Mantle cell lymphoma
t(11;14)
Factor V Leiden in pregnancy
If no other DVTs in patient or first degree relative then do not need to have LMWH
Auer rods
AML
- acute history of lethargy
- splenomegaly
- pancytopenia
Burkitts genetic
c-Myc
CML genetic
BRC-ABL
Nephrotic syndrome cause of clots
Protein S deficiency
Vegan which vitamin are they likely to be deficient in
B12
Diabetes insipidus, what is it related to
Sickle cell disease
Beta thalassaemia diagnostic
HbA2 will be raised
Myeloma investigstions
Serum B2 microglobulin for disease severity
Hyperviscosity symptoms
Nose bleeds, papilloedema, distended retinal vasculature
Neutropenic sepsis antibiotics
TAZ
Capecatibine over 5 fluoracil
Oral administration
BCR/TBL translocation
codes for production of tyrosine kinase
If a patient is diagnosed with AML what is the second most important test
Clotting (at risk of DIC, would indicate acute promyelotic leukaemia)
Ank spon biologics
NSAIDS then TNF alpha blockers e.g. adalimumab, etanercept, infliximab
RA HLA
DR4
Cyclophosphamide SE
Haemorrhagic cystitis
Bleomycin SE
lung fibrosis
Methotrexate SE
Myelosuppression, liver fibrosis, lung fibrosis
Fluorouracil SE
Myelosuppression, mucositis, dermatitis
Vincristine SE
Peripheral neuropathy
Docetaxel SE
Neutropenia
Cisplatin SE
Ototoxicity
Anastrozole investigations prior to treatment
DEXA scan as at increased risk of osteoporosis
Trastuzamab moa
HER2 monoclonal antibody
Tamoxifen moa
Antagonist and a partial agonist of oestrogen receptor
Philadelphia chromosome
T(9;22) CML
Ewings sarcoma gene
t(15;22)
Acute promyelotic leukaemia gene
t(15;17)
Hodgkins first line chemo
ABVD (second line is RCHOP, better outcomes but worse SEs)
Hodgkins best subtype (best prognosis)
Lymphocyte predmoniant
Hodgkins worst subtype (worst prognosis)
Lymphocyte depleted
ALL epidemiology
Kids and down syndrome
AML epidemiology
Auer rods
CLL epidemiology
Warm haemolytic anaemia (IgG), Richter’s transformation (CLL transforms into diffuse large B cell lymphoma), smudge cells
CML epidemiology
3 phases
associated with philadelphia chromosome
When is the philadelphia chromosome a poor prognostic outcome
In AML or ALL
Poor prognostic indicator for AML
Cytogenic: chromosome 5 or 7 deletion
>20% blast cells at diagnosis
CLL poor prognostic indicators
CD38 expression positive
TP53 mutation
Deletions of part of the short arm of chromosome 17 (del 17p)
CLL good prognostic indicators
Deletion of the long arm of chromosome 13 (del 13q) is the most common abnormality being seen in around 50% of patients
Myeloma Ig
IgM
Myeloma prognostic indicator
B2-microglobulin
Sickle cell genetics
Valine is substituted for glutamic acid in position 6 in the beta chain
Why do you need to replace folate before B12 in B12 deficiency
Otherwise will cause subacute degeneration of the cord
G6PD deficiency
Heinz bodies, bite and blister cells
Burkitts
c-myc, t(18;14)
Starry star
Tumour lysis syndrome
hyperkalaemia, hyperphosphataemia, hypocalcaemia, hyperuricaemia, acute renal failure
Hereditary angioedema
C1 inhibitor during an attack
Low C2 and C4 normally low C4 is monitored
TTP management
Plasma exchange
Heparin induced thrombocytopenia management
argatroban
Warm haemolytic anaemia Ig
IgG
Cold haemolytic anaemia Ig
IgM
Normal pO2 but decreased O2 saturation on ABG
CO poisoning
Lead poisoning
Dimercaptosuccinic acid
Mx: ascorbic acid
Anaphylaxis
IgA